Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Gross Profit (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Gross Profit for 16 consecutive years, with $22.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit rose 34.86% to $22.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $82.5 million, a 19.06% increase, with the full-year FY2024 number at $68.2 million, up 22.98% from a year prior.
  • Gross Profit was $22.0 million for Q3 2025 at Xtant Medical Holdings, down from $24.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $24.3 million in Q2 2025 to a low of $7.2 million in Q3 2021.
  • A 5-year average of $13.4 million and a median of $12.5 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: decreased 22.23% in 2021, then soared 106.32% in 2023.
  • Xtant Medical Holdings' Gross Profit stood at $7.7 million in 2021, then increased by 7.97% to $8.3 million in 2022, then skyrocketed by 106.32% to $17.1 million in 2023, then fell by 6.49% to $16.0 million in 2024, then surged by 37.24% to $22.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Gross Profit are $22.0 million (Q3 2025), $24.3 million (Q2 2025), and $20.2 million (Q1 2025).